Product Information
PANTOPRAZOLE DR 40 MG SUSP PKT is a generic product labeled by Ajanta Pharma USA Inc., priced at $4.2008 per EA under NDC 27241025611. Its NADAC has been published 163 times since Jul 12, 2023.
FDA first approved this application on Feb 9, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241025611
Classification
Generic
Dosage Form
FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PANTOPRAZOLE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA217416FDA Approved
2/9/2023
TE Code
AB
On Market Since
2/9/2023
Pharmacological Classes
Price Statistics
The NADAC for PANTOPRAZOLE DR 40 MG SUSP PKT has been published 163 times since Jul 12, 2023, and over the history we have for it it has declined 54.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.2008 per EA |
|---|---|
| All-time high | $12.2693 (Apr 10, 2024) |
| All-time low | $4.0255 (Apr 22, 2026) |
| 52-week high | $6.0544 |
| 52-week low | $4.0255 |
| Median price | $6.8328 |
| Average price | $7.4067 |
| Largest weekly change | -32.5% (May 22, 2024) |
| Weeks tracked | 163 |
| Tracking since | Jul 12, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PANTOPRAZOLE DR 40 MG SUSP PKT?
The current National Average Drug Acquisition Cost (NADAC) for PANTOPRAZOLE DR 40 MG SUSP PKT, manufactured by Ajanta Pharma USA Inc., is $4.2008 per EA (NDC 27241025611), effective Aug 19, 2026.
How has the price of PANTOPRAZOLE DR 40 MG SUSP PKT changed over time?
Over the history we have for it, the NADAC for PANTOPRAZOLE DR 40 MG SUSP PKT has declined 54.2%. It has been tracked across 163 weekly CMS publications since Jul 12, 2023.
What are the highest and lowest recorded NADAC prices for PANTOPRAZOLE DR 40 MG SUSP PKT?
Since Jul 12, 2023, the NADAC for PANTOPRAZOLE DR 40 MG SUSP PKT has ranged from a low of $4.0255 (Apr 22, 2026) to a high of $12.2693 (Apr 10, 2024), with a median of $6.8328 per EA.
Are there cheaper alternatives to PANTOPRAZOLE DR 40 MG SUSP PKT?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PANTOPRAZOLE DR 40 MG SUSP PKT in a comparable dosage form, but none are currently priced below it.
Who manufactures PANTOPRAZOLE DR 40 MG SUSP PKT?
PANTOPRAZOLE DR 40 MG SUSP PKT (NDC 27241025611) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.